Autolus Therapeutics plc ADR (NASDAQ:AUTL) has a beta value of 2.14 and has seen 0.44 million shares traded in the recent trading session. The company, currently valued at $1.10B, closed the recent trade at $4.14 per share which meant it lost -$0.17 on the day or -3.94% during that session. The AUTL stock price is -79.95% off its 52-week high price of $7.45 and 51.45% above the 52-week low of $2.01. The 3-month trading volume is 1.53 million shares.
Autolus Therapeutics plc ADR (NASDAQ:AUTL) trade information
Sporting -3.94% in the red today, the stock has traded in the red over the last five days, when the AUTL stock price touched $4.14 or saw a rise of 6.55%. Year-to-date, Autolus Therapeutics plc ADR shares have moved -35.71%, while the 5-day performance has seen it change -3.50%. Over the past 30 days, the shares of Autolus Therapeutics plc ADR (NASDAQ:AUTL) have changed 3.24%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Autolus Therapeutics plc ADR (AUTL) estimates and forecasts
Figures show that Autolus Therapeutics plc ADR shares have outperformed across the wider relevant industry. The company’s shares have lost -7.80% over the past 6 months, with this year growth rate of 35.00%, compared to 15.40% for the industry.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 3.32% over the past 5 years.
AUTL Dividends
Autolus Therapeutics plc ADR is expected to release its next earnings report in July this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
